BSE: 524470 - Syncom Formulations (India) Limited

半年間の収益性: -32.56%
配当利回り: 0.00%

プロモーションスケジュール Syncom Formulations (India) Limited


会社について Syncom Formulations (India) Limited

Syncom Formulations (India) Limited, a pharmaceutical company, discovers, develops, manufactures, and markets a range of healthcare products in India. The company offers approximately 300 pharmaceutical formulations in various dosage forms, such as tablets, capsules, liquids orals, liquid vials and ampoules injections, dry vial injections, dry syrups, ointments, inhalers, and herbals.

さらに詳しく
Its products comprise generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also offers histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it exports active pharmaceutical ingredients and surgical products; agro and confectionary products comprising rice, wheat flour, chickpeas, soy doc, biscuits, and candies; and fasteners, steel bars, roofing sheets, and jute bags, as well as metal scrap. Additionally, the company rents properties. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.

Industry Biotechnology
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0
Дивиденд ао 0.03
Сайт http://www.syncomformulations.com
Цена ао 15.61
1日あたりの価格変動: +2.02% (15.33)
週ごとの価格変動: -2.25% (16)
月ごとの料金変更: -10.98% (17.57)
3ヶ月間の価格変動: -27.29% (21.51)
半年間の価格変動: -32.56% (23.19)
年間の価格変動: +12.52% (13.9)
3年間の価格推移: -7.84% (16.97)
5年間の価格推移: +2 200% (0.68)
10年間の価格推移: 0% (15.64)
年初からの価格変動: -21.05% (19.81)

過小評価

名前 意味 学年
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
合計: 2.5

効率

名前 意味 学年
ROA, % 0 0
ROE, % 0 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0.8571 8.57
合計: 3.46

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 20.07 4
収益性 Ebitda, % 0 0
収益性 EPS, % 50.26 7
合計: 4

スーパーバイザー 役職 支払い 生年
Mr. Kedarmal Shankarlal Bankda Whole-Time Director & Exec. Chairman 1952 (73 年)
Mr. Vijay Shankarlal Bankda MD and Exec. & Non Independent Director 1958 (67 年)
Mr. Ankit Kedarmal Bankda Chief Financial Officer 1987 (38 年)
Mr. Shubham Dubey C.S. Company Sec. & Compliance Officer
Mr. Rakesh Ch. Srivastava VP of Marketing 1962 (63 年)
Ms. Rinki Ankit Bankda Whole Time Director 1987 (38 年)
Suresh B. Paithankar VP of International Marketing 1970 (55 年)

住所: India, Indore, 207 Saket Nagar - Googleマップで開く, Yandexマップを開く
Webサイト: http://www.syncomformulations.com